Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder

• Published in: PharmacoEconomics Vol. 18; no. 4; pp. 383 - 391
• Main Authors: Mavissakalian, M R, Schmier, J K, Flynn, J A, Revicki, D A
• Format: Journal Article
• Language: English
• Published: New Zealand Springer Healthcare | Adis 01.10.2000
• Series: PharmacoEconomics
• Subjects: Clinical Trials as Topic; Cost analysis; Cost utility; Cost-Benefit Analysis; Health Care Costs; Health technology assessment; Humans; Imipramine; Imipramine - administration & dosage; Panic disorder; Panic Disorder - drug therapy; Pharmacoeconomics; Quality-Adjusted Life Years; Tricyclic antidepressants

To examine the medical costs and effectiveness of acute treatment with imipramine versus acute treatment plus 2 different maintenance therapies for panic disorder. A clinical decision model was constructed to estimate 18-month costs and outcomes associated with these treatment scenarios based on the...